A common nasal disorder with nasal pruritus, sneezing, rhinorrhea, and nasal congestion is allergical rhinitis. Exaggerated pain responses (hyperalgesia), pressure, pain (allodynia), and hyposmia are some of the other symptoms of the illness. It is estimated that the global allergic rhinitis treatment market amounts to US$ 13,950.7 million and that US$ 17,863.6 million is to be achieved by 2027.
Get Your FREE Sample Copy of the Allergic Rhinitis Treatment Market Report 2021
Drivers
Increasing prevalence of allergic rhinitis is expected to boost over the forecast period growth of the global market for allergic rhinitis. For instance, the U.S. recorded 5.2 million and 19.2 million cases of hay fever in children aged 18 years and below and individuals aged 18 and above respectively in 2018, as per the Centers for Disease Control and Prevention (CDC).
Furthermore, increased rates of patients’ self-medication and the supply of OTC medications would also help increase the demand for treatment for allergic rhinitis.
Restraints
Lack of potential cure is expected to limit growth of the global rhinitis treatment market. However, antihistamine medications and nasal sprays help minimize the impact of the condition.
Furthermore, allergic rhinitis symptoms may match other diseases or medical issues that are likely to restrict the expansion of the market.
Ask for PDF sample copy of the Allergic Rhinitis Treatment market report @ https://www.coherentmarketinsights.com/insight/request-pdf/1201
Opportunities
For companies in the global allergic rhinitis treatment market, the high prevalence of asthma is projected to provide lucrative growth opportunities. As per the Global Asthma Report 2018, around 300 million people worldwide suffer from asthma, with the figure anticipated to rise to 100 million by 2025.
Furthermore, R&D in allergic rhinitis is expected to contribute to market expansion. For instance, Glenmark Pharmaceuticals revealed in May 2019 that a Phase 3 study of Ryaltris, an experimental fixed-dose composition nasal spray for the treatment of seasonal allergic rhinitis, had shown positive outcomes.
The global allergic rhinitis treatment market was worth US$ 13,450.3 million in 2019 and is expected to be worth US$ 17,863.6 million by 2027, growing at a CAGR of 3.6 % between 2020 and 2027.
Key takeaways
New medications for increasing the sleep quality for allergic rhinitis patients are being researched and developed in the market. For instance, ALK presented a fresh analysis of clinical trial data in February 2019 revealing that their sublingual allergy immunotherapy pill for the cure of house dust mite (HDM)-related allergies can considerably enhance allergic rhinitis patients’ sleep quality.
In order to increase their market share, key players in the sector are focusing on establishing alliances. For instance, Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals Ltd. based in Switzerland, entered into an exclusive license agreement with Hikma Pharmaceuticals PLC in February 2020 for the commercialization of its new nasal spray Ryaltris for the treatment of allergic rhinitis in the U.S.
Buy Now this Premium Report to Grow your Business: https://www.coherentmarketinsights.com/insight/buy-now/1201
Reasons to Purchase this Report
• Current and future of global Allergic Rhinitis Treatment market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
“Limited Time Offer”
Access insightful study with over 150+ pages, list of tables & figures, profiling 20+ companies.
We also offer 15% FREE Report customization.
Get This premium report with Instant US$ 2000 discount @ https://www.coherentmarketinsights.com/promo/buynow/1201
Competitive Landscape
Major companies working in the global allergic rhinitis treatment market include, AstraZeneca, Johnson & Johnson, Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Merck & Co., ALK, Glenmark Pharmaceuticals Ltd., Mylan, Alcon (Novartis AG), GlaxoSmithKline PLC, Sanofi S.A., Unichem Laboratories, and Innovus Pharmaceuticals, Inc.
Key developments
To grow their product portfolio, main players in the industry are focusing on getting new treatments approved and launched. For instance, ALK completed the marketing authorization process in 17 European countries for their tree sublingual allergy immunotherapy pill ITULAZAX in June 2019.
Similarly, Mylan unveiled Dymista, a new type of therapy for allergic rhinitis, in Malaysia in November 2018.
View Press Release For More Information
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Treatment Type
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Regulatory Scenario
- PEST Analysis
- COVID-19 Impact Analysis
- Market Dynamics
- Global Allergic Rhinitis Treatment Market, By Treatment Type, 2019 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Immunotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- SCIT
- SLITD
- SLITT
- Anti-histamines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Decongestants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Leukotriene Receptor Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Introduction
- Global Allergic Rhinitis Treatment Market, By Route of Administration, 2019 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Nasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Intraocular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Allergic Rhinitis Treatment Market, By Distribution Channel, 2019 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- E-Commerce
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Allergic Rhinitis Treatment Market, By Regions, 2019 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Section
- References
- Research Methodology
- About us and Sales Contact
Other Exclusive Reports:
Organ Transplant Immunosuppressant Drugs Market
Morphine, Buprenorphine, and Other Drugs Market
Pain Management Therapeutics Market
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837